Inflammation in primarily and secondarily‐enucleated eyes with uveal melanoma.

Autor: VU, THK, BRONKHORST, IHG, VERSLUIS, M, MARINKOVIC, M, VAN DUINEN, SG, VROLIJK, J, LUYTEN, GPM, JAGER, MJ

Publikováno v: Acta Ophthalmologica (1755375X); Sep2011 Supplement S248, Vol. 89, p0-0, 1p

Protein and mRNA Expression in Uveal Melanoma Cell Lines Are Related to GNA and BAP1 Mutation Status.

Autor: Gelmi MC; Department of Ophthalmology, Leiden University Medical Center, Leiden, The Netherlands., de Ru AH; Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, The Netherlands., van Veelen PA; Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, The Netherlands., Tjokrodirijo RTN; Center for Proteomics and Metabolomics, Leiden University Medical Center, Leiden, The Netherlands., Stern MH; Inserm U830, DNA Repair and Uveal Melanoma (D.R.U.M.), Institut Curie, PSL Research University, Paris, France., Houy A; Inserm U830, DNA Repair and Uveal Melanoma (D.R.U.M.), Institut Curie, PSL Research University, Paris, France., Verdijk RM; Department of Pathology, Ophthalmic Pathology Section, Erasmus MC, Rotterdam, The Netherlands.; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands., Vu THK; Department of Ophthalmology, Leiden University Medical Center, Leiden, The Netherlands., Ksander BR; Schepens Eye Research Institute, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, United States., Vaarwater J; Department of Clinical Genetics, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.; Department of Ophthalmology, Erasmus MC, Rotterdam, The Netherlands., Kilic E; Department of Ophthalmology, Erasmus MC, Rotterdam, The Netherlands., Brosens E; Department of Clinical Genetics, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Jager MJ; Department of Ophthalmology, Leiden University Medical Center, Leiden, The Netherlands.

Publikováno v: Investigative ophthalmology & visual science [Invest Ophthalmol Vis Sci] 2024 Jul 01; Vol. 65 (8), pp. 37.

Time Trends in the Treatment and Survival of 5036 Uveal Melanoma Patients in The Netherlands over a 30-Year Period.

Autor: Tong TML; Department of Medical Oncology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands.; Department of Radiology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands., Bastiaannet E; Department of Epidemiology, Biostatistics and Prevention, University of Zurich, Rämistrasse 71, 8006 Zürich, Switzerland., Speetjens FM; Department of Medical Oncology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands., Blank CU; Department of Medical Oncology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands.; Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands., Luyten GPM; Department of Ophthalmology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands., Jager MJ; Department of Ophthalmology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands., Marinkovic M; Department of Ophthalmology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands., Vu THK; Department of Ophthalmology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands., Rasch CRN; Department of Radiation Oncology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands., Creutzberg CL; Department of Radiation Oncology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands., Beenakker JM; Department of Radiology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands.; Department of Ophthalmology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands.; Department of Radiation Oncology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands., Hartgrink HH; Department of Surgery, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands., Bosch JJJ; Department of Medical Oncology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands.; Centre for Human Drug Research, Zernikedreef 8, 2333 CL Leiden, The Netherlands., Kiliç E; Department of Ophthalmology, Erasmus Medical Center, Dr. Molewaterplein 40, 3015 GD Rotterdam, The Netherlands., Naus NC; Department of Ophthalmology, Erasmus Medical Center, Dr. Molewaterplein 40, 3015 GD Rotterdam, The Netherlands., Yavuzyigitoglu S; Department of Ophthalmology, Erasmus Medical Center, Dr. Molewaterplein 40, 3015 GD Rotterdam, The Netherlands., van Rij CM; Department of Radiation Oncology, Erasmus Medical Center, Dr. Molewaterplein 40, 3015 GD Rotterdam, The Netherlands., Burgmans MC; Department of Radiology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands., Kapiteijn EHW; Department of Medical Oncology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands.

Publikováno v: Cancers [Cancers (Basel)] 2023 Nov 15; Vol. 15 (22). Date of Electronic Publication: 2023 Nov 15.

Magnetic Resonance Imaging in the Clinical Care for Uveal Melanoma Patients-A Systematic Review from an Ophthalmic Perspective.

Autor: Jaarsma-Coes MG; Department of Ophthalmology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.; Department of Radiology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands., Klaassen L; Department of Ophthalmology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.; Department of Radiology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.; Department of Radiation Oncology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands., Marinkovic M; Department of Ophthalmology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands., Luyten GPM; Department of Ophthalmology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands., Vu THK; Department of Ophthalmology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands., Ferreira TA; Department of Radiology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands., Beenakker JM; Department of Ophthalmology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.; Department of Radiology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.; Department of Radiation Oncology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.

Publikováno v: Cancers [Cancers (Basel)] 2023 May 30; Vol. 15 (11). Date of Electronic Publication: 2023 May 30.

Increased Histological Tumor Pigmentation in Uveal Melanoma Is Related to Eye Color and Loss of Chromosome 3/BAP1.

Autor: Gelmi MC; Department of Ophthalmology, Leiden University Medical Center, Leiden, The Netherlands., Wierenga APA; Department of Ophthalmology, Leiden University Medical Center, Leiden, The Netherlands., Kroes WGM; Department of Clinical Genetics, Leiden University Medical Center, Leiden, The Netherlands., van Duinen SG; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands., Karuntu JS; Department of Ophthalmology, Leiden University Medical Center, Leiden, The Netherlands., Marinkovic M; Department of Ophthalmology, Leiden University Medical Center, Leiden, The Netherlands., Bleeker JC; Department of Ophthalmology, Leiden University Medical Center, Leiden, The Netherlands., Luyten GPM; Department of Ophthalmology, Leiden University Medical Center, Leiden, The Netherlands., Vu THK; Department of Ophthalmology, Leiden University Medical Center, Leiden, The Netherlands., Verdijk RM; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands.; Section Ophthalmic Pathology, Department of Pathology, Erasmus MC University Medical Center, Rotterdam, The Netherlands., Jager MJ; Department of Ophthalmology, Leiden University Medical Center, Leiden, The Netherlands.

Publikováno v: Ophthalmology science [Ophthalmol Sci] 2023 Mar 11; Vol. 3 (3), pp. 100297. Date of Electronic Publication: 2023 Mar 11 (Print Publication: 2023).